Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-20 4:10 pm Purchase | 2026-07-13 | 13G | PRECISION BIOSCIENCES INC DTIL | Lynx1 Capital Management LP | 1,390,611 5.400% | 396,698 (+39.91%) | Filing History |
| 2026-07-02 9:19 pm Purchase | 2026-06-25 | 13D | PASSAGE BIO INC PASG | Lynx1 Capital Management LP | 673,759 21.000% | 50,055 (+8.03%) | Filing History |
| 2026-05-18 9:30 pm Purchase | 2026-03-31 | 13G | GH RESH PLC SHS GHRS | Lynx1 Capital Management LP | 10,763,288 17.400% | 1,306,666 (+13.82%) | Filing History |
| 2026-05-18 9:30 pm Purchase | 2026-03-31 | 13G | STOKE THERAPEUTICS INC STOK | Lynx1 Capital Management LP | 4,763,673 8.100% | 642,429 (+15.59%) | Filing History |
| 2026-05-15 4:31 pm Sale | 2025-12-31 | 13G | ALLOGENE THERAPEUTICS INC ALLO | Lynx1 Capital Management LP | 0 0.000% | -10,874,723 (Position Closed) | Filing History |
| 2026-05-15 4:30 pm Sale | 2026-03-31 | 13G | GH RESH PLC SHS GHRS | Lynx1 Capital Management LP | 9,456,622 15.200% | -949,953 (-9.13%) | Filing History |
| 2026-05-15 4:30 pm Sale | 2026-03-31 | 13G | STOKE THERAPEUTICS INC STOK | Lynx1 Capital Management LP | 4,121,244 7.000% | -1,065,947 (-20.55%) | Filing History |
| 2026-05-06 4:21 pm Purchase | 2026-04-29 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Lynx1 Capital Management LP | 3,013,949 5.100% | 3,013,949 (New Position) | Filing History |
| 2026-04-02 12:01 pm Purchase | 2026-03-31 | 13G | KORRO BIO INC KRRO | Lynx1 Capital Management LP | 1,538,296 10.700% | 804,663 (+109.68%) | Filing History |
| 2026-02-17 1:46 pm Sale | 2025-12-31 | 13G | IBIO INC PAR $0.001 IBIO | Lynx1 Capital Management LP | 0 0.000% | -878,492 (Position Closed) | Filing History |
| 2026-02-17 1:46 pm Sale | 2025-12-31 | 13G | PRECISION BIOSCIENCES INC DTIL | Lynx1 Capital Management LP | 993,913 4.100% | -48,683 (-4.67%) | Filing History |
| 2026-02-17 1:45 pm Purchase | 2025-12-31 | 13G | GH RESH PLC SHS GHRS | Lynx1 Capital Management LP | 10,406,575 16.800% | 1,805,386 (+20.99%) | Filing History |
| 2026-02-17 1:45 pm Purchase | 2025-12-31 | 13G | C4 THERAPEUTICS INC CCCC | Lynx1 Capital Management LP | 7,098,133 7.300% | 217,606 (+3.16%) | Filing History |
| 2026-01-05 5:40 pm Purchase | 2025-12-23 | 13G | KORRO BIO INC KRRO | Lynx1 Capital Management LP | 733,633 7.800% | 733,633 (New Position) | Filing History |
| 2025-12-29 4:33 pm Unchanged | 2025-12-26 | 13D | NEUPHORIA THERAPEUTICS INC NEUP | Lynx1 Capital Management LP | 875,328 16.300% | 0 (Unchanged) | Filing History |
| 2025-12-02 08:20 am Unchanged | 2025-12-02 | 13D | NEUPHORIA THERAPEUTICS INC NEUP | Lynx1 Capital Management LP | 875,328 16.300% | 0 (Unchanged) | Filing History |
| 2025-11-28 09:09 am Unchanged | 2025-11-28 | 13D | NEUPHORIA THERAPEUTICS INC NEUP | Lynx1 Capital Management LP | 875,328 16.300% | 0 (Unchanged) | Filing History |
| 2025-11-18 08:25 am Unchanged | 2025-11-18 | 13D | NEUPHORIA THERAPEUTICS INC NEUP | Lynx1 Capital Management LP | 875,328 16.300% | 0 (Unchanged) | Filing History |
| 2025-11-14 2:02 pm Purchase | 2025-09-30 | 13G | PRECISION BIOSCIENCES INC DTIL | Lynx1 Capital Management LP | 1,042,596 8.800% | 276,545 (+36.10%) | Filing History |
| 2025-11-14 2:01 pm Purchase | 2025-09-30 | 13G | PASSAGE BIO INC PASG | Lynx1 Capital Management LP | 623,704 19.600% | 160,856 (+34.75%) | Filing History |